NCT03453619 Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies Status COMPLETED Phase PHASE2
NCT03393013 A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis Status COMPLETED Phase PHASE1/PHASE2
NCT03385564 An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis Status COMPLETED Phase PHASE2
NCT03214731 Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis Status UNKNOWN Phase PHASE4
NCT03201406 Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney Disease Status UNKNOWN Phase N/A
NCT03174587 Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis Status COMPLETED Phase PHASE1
NCT02954939 The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis Status RECRUITING Phase NA
NCT02949349 Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis Status COMPLETED Phase PHASE2
NCT02770170 Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis Status COMPLETED Phase PHASE2
NCT02645565 Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis Status COMPLETED Phase PHASE4
NCT02630628 Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis Status COMPLETED Phase PHASE3
NCT02550652 A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN) Status COMPLETED Phase PHASE2
NCT02547922 Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis Status COMPLETED Phase PHASE2